Clinical trial
Dynamic Measures of Neurochemistry in Mood Disorders
NCT00178828 · Vanderbilt University Medical Center, Other · Completed
Key facts
| NCT number | NCT00178828 |
|---|---|
| Title | Dynamic Measures of Neurochemistry in Mood Disorders |
| Official title | Dynamic Measures of Neurochemistry in Mood Disorders |
| Lead sponsor | Vanderbilt University Medical Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | sertraline, bupropion |
| Enrollment | 42 |
| Start date | Oct 1, 2002 |
| Primary completion | Apr 1, 2013 |
| Completion | Apr 1, 2013 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: